Inhibition of Intravascular Thrombosis and Vascular Smooth Muscle Cell Proliferation by Gene Therapy

Moshe Y Flugelman

doi:10.1055/s-0038-1642712

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1995; 74(01): 406-410
DOI: 10.1055/s-0038-1642712

Symposium

Vaascular Growth Factor

Schattauer GmbH Stuttgart

Inhibition of Intravascular Thrombosis and Vascular Smooth Muscle Cell Proliferation by Gene Therapy

Moshe Y Flugelman

Department of Cardiology, Lady Davis Carmel Medical Center and the Faculty of Medicine, Technion IIT, Haifa, Israel

› Author Affiliations

Abstract

PDF Download

PDF (241 kb)

References

References
1 Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-809
2 Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndrome. N Eng I Med 1992; 326: 242-250-310-318
3 Flugelman MY, Virmani R, Correa R, Yu Z-X, Farb A, Leon BM, Fu YM, Casscells W, Epstein SE. Smooth muscle cell abundance and fibroblast growth factors in coronary lesions of patients with non fatal unstable angina: a clue to the mechanism of transformation from the stable to the unstable clinical state. Circulation 1993; 88: 2493-2500
4 Strauss BH, Chisholm RJ, Keeley FW, Gotlieb AI, Logan RA, Armstrong PW. Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Circ Res 1994; 75: 650-658
5 Casscells W. Endothelial and smooth muscle cell migration: critical factors in restenosis. Circulation 1992; 86: 723-729
6 Ferns GA A, Raines EW, Sprugel KH, Motani AS, Reidy MA, Ross R. Inhibition of neointimal smooth muscle cells accumulation after angioplasty by an antibody to PDGF. Science 1991; 253: 1129-1132
7 Wilcox JH. Thrombin and other potential mechanisms underlying restenosis. Circulation 1991; 84: 432-435
8 Bar Shavit R, Benezra M, Sabbah V, Bode W, Vlodavsky I. Thrombin as a multifunctional protein: induction of cell adhesion and proliferation. Am J Res Cell and Moll Biol 1992; 6: 123-130
9 Benezra M, Vlodavsky I, Ishai-Michaeli R, Neufeld G, Bar-Shavit R. Thrombin-induced release of active basic fibroblast growth factor-heparan sulfate complexes from subendothelial extra-cellular matrix. Blood 1993; 82: 3324-3332
10 Thyberg J, Hedin U, Sjolund M, Palmberg L, Bottger BA. Regulation of differentiated properties and proliferation of arterial smooth muscle cells. Arteriosclerosis 1990; 10: 966-990
11 Anderson WF. Human gene therapy. Science 1992; 256: 808-813
12 Mulligan RC. The basic science of gene therapy. Science 1993; 260: 926-932
13 Swain JL. Gene therapy; a new approach to the treatment of cardiovascular disease. Circulation 1989; 80: 1495-1496
14 Riessen R, Isner JM. Prospects for site-specific delivery of pharmacologic and molecular therapies. J Am J Cardiol 1994; 23: 1234-1244
15 Nabel EG, Plautz G, Boyce FM, Stanley JC, Nabel GJ. Recombinant gene expression in vivo within endothelial cells of the arterial wall. Science 1989; 244: 1342-1344
16 Flugelman MY, Leon MB, Bowman RL, Virmani R, Anderson WF, Dichek DA. Retention of seeded cells on balloon expanded stents under flow conditions. Circulation 1990; (Suppl. 82) Suppl. 3: 72
17 Flugelman MY, Virmani R, Leon MB, Bowman RL, Dichek DA. Genetically engineered endothelial cells remain adherent and viable after stent deployment and exposure to flow in vitro. Circ 1992; 70: 348-354
18 Flugelman MY, Rome JJ, Virmani R, Newman KD, Dichek DA. Detection of genetically engineered endothelial cells seeded on endovascular prosthesis ten days after in vivo deployment. J Mol Cell Cardiol 1993; 25 Suppl (Suppl. 01) 38S
19 Flugelman MY, Jaklitsch MT, Newman KD, Casscells SW, Bratt-hauer GL, Dichek DA. Low levels in vivo gene transfer into the arterial wall through a perforated balloon catheter. Circulation 1992; 85: 1110-1117
20 Schneider M, French BA. The advent of adenovirus-gene therapy for cardiovascular disease. Circulation 1993; 88: 1937-1942
21 Rome JJ, Shayani V, Flugelman MY, Newman KD, Farb A, Virmani R, Dichek DA. Anatomic barriers determine the distribution of in vivo gene transfer into the arterial wall: modeling with microscopic tracer particles and verification with a recombinant adenoviral vector. Atherosclerosis and Thrombosis 1994; 14: 148-161
22 Serruys PW, de Jaegere P, Kiemeneij F. et al A comparison of balloon expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994; 331: 489-495
23 Fischman DL, Leon MB, Bairn DS. et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994; 331: 496-501
24 Correa R, Yu Z-X, Flugelman MY, Roberts WC, Kent K, Ferrans VJ, Casscells W. Evidence of fibroblast growth factor expression in smooth muscle cells and macrophages of atherosclerotic and restenotic human arteries. Circulation 1991; 84 Suppl (Suppl. 02) S460
25 Epstein SE, Speir E, Unger EF, Guzman RJ, Finkel T. The basis molecular strategies for treating coronary restenosis after angioplasty. J Am Coll Cardiol 1994; 23: 1278-1288
26 Dichek DA, Nussbaum O, Degen SJ F, Anderson WF. Enhancement of fibrinolytic activity of sheep endothelial cells by retroviral vector-mediated gene transfer. Blood 1991; 77: 533-541
27 Lindner V, Riedy MA. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Natl Acad Sci USA 1991; 88: 3739-3743
28 Kasahara N, Dozy AM, Kan YW. Tissue-specific targeting of retroviral vectors through ligand-receptor interactions. Science 1994; 266: 1373-1376
29 Lee SW, Trapnell BC, Rade JJ, Virmani R, Dichek DA. In vivo adenoviral vector-mediated gene transfer into balloon-injured rat carotid arteries. Circulation Research 1993; 73: 797-807
30 Schulick AH, Newman KD, Dichek DA. A therapeutic window for in vivo adenoviral vector mediated gene transfer. Circulation 1994; 90 Suppl (Suppl. 04) I516
31 Feldman LJ, Steg PG, Zheng LP, Kearney M, Barry JJ, Perri-caudet M, Isner JM. Percutaneous adeno-mediated gene delivery to normal and atherosclerotic arteries in vivo: a comparative study. Circulation 1994; 90 Suppl (Suppl. 04) I 517
32 Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992; 359: 843-845
33 Ohno T, Gordon D, San H, Pompili VJ, Imperiale MJ, Nabel GJ, Nabel EG. Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science 1994; 265: 781-784
34 Morishita R, Gibbons GH, Ellison KE, Masatoshi Nakajima, von der Leyen H, Zhang L, Kaneda Y, Ogihara T, Dzau VJ. Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides. J Clin Invest 1994; 93: 1458-1464
35 Coghlan A. Gene superclub signs up top players. New Scientist 1994; 1952: 4